Stem Cell: Caladrius Biosciences To Present At Multiple Upcoming October Conferences

css" rel"stylesheet" href"http://www.globenewswire.com/styles/gnw_nitf.css" />BASKING RIDGE, N.J., Oct. 1, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS), a cell therapy company combining an industry-leading external development and manufacturing provider with a development pipeline including a Phase 3 clinical program in immuno-oncology and a portfolio of...